Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	10.69	164.75	148.83
Graham Fair Price	29.71	188960.30	145678.62
PEG	-83.03	0.03	-0.19
Price/Book	18.56	0.57	0.48
Price/Cash Flow	44.72	4.28	2.96
Prices/Earnings	-34.60	2.41	3.69
Price/Sales	44.90	1.53	1.06
Price/FCF	44.72	4.28	2.96
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-50.83	1.00	2.03
Operating Margin	-99.85	< 0.005	-1.74
ROA	73.09	< 0.005	< 0.005
ROE	0.03	0.06	81.28
ROIC	-0.59	< 0.005	-99.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.23	-0.04	485.75
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-15.83	1.00	-93.68
EPS QOQ	-0.19	0.75	285.39
FCF QOQ	0.56	-0.21	-62.07
Revenue QOQ	0.17	-0.21	24.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.11	0.12	8.07
Quick Ratio	0.03	0.03	-8.08
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	170485.64	164244.62	-3.66
Cash	25338.11	19334.34	-23.69
Capex	-312.21	-217.75	30.26
Free Cash Flow	27568.60	21758.11	-21.08
Revenue	77218.69	60865.22	-21.18
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.06	0.08	30.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.01	22.42	645.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating